company background image
RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E CASE:RMDA Stock Report

Last Price

ج.م2.85

Market Cap

ج.م2.8b

7D

-3.1%

1Y

16.3%

Updated

08 Dec, 2022

Data

Company Financials +
RMDA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance5/6
Financial Health5/6
Dividends0/6

RMDA Stock Overview

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E., together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals and nutraceuticals in Egypt.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E
Historical stock prices
Current Share Priceج.م2.85
52 Week Highج.م3.17
52 Week Lowج.م1.80
Beta0.21
1 Month Change7.55%
3 Month Change4.40%
1 Year Change16.33%
3 Year Change-11.92%
5 Year Changen/a
Change since IPO-16.49%

Recent News & Updates

Recent updates

Shareholder Returns

RMDAEG PharmaceuticalsEG Market
7D-3.1%5.4%6.8%
1Y16.3%20.9%22.1%

Return vs Industry: RMDA underperformed the EG Pharmaceuticals industry which returned 18.1% over the past year.

Return vs Market: RMDA underperformed the EG Market which returned 22.3% over the past year.

Price Volatility

Is RMDA's price volatile compared to industry and market?
RMDA volatility
RMDA Average Weekly Movement5.3%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement5.8%
10% most volatile stocks in EG Market9.0%
10% least volatile stocks in EG Market3.6%

Stable Share Price: RMDA is not significantly more volatile than the rest of EG stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: RMDA's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1986n/aAmr Morsyhttps://www.ramedapharma.com

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E., together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals and nutraceuticals in Egypt. It manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use; and diagnostic reagents for individuals, laboratories, and hospitals. The company offers a portfolio of products in various therapeutic areas, such as anti-infective, anti-diabetic, respiratory, ophthalmology, gastrointestinal tract, cardiovascular, central nervous system, vitamins, and analgesics.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Fundamentals Summary

How do Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E's earnings and revenue compare to its market cap?
RMDA fundamental statistics
Market Capج.م2.78b
Earnings (TTM)ج.م254.21m
Revenue (TTM)ج.م1.49b

10.9x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
RMDA income statement (TTM)
Revenueج.م1.49b
Cost of Revenueج.م760.92m
Gross Profitج.م726.08m
Other Expensesج.م471.87m
Earningsج.م254.21m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.26
Gross Margin48.83%
Net Profit Margin17.10%
Debt/Equity Ratio57.8%

How did RMDA perform over the long term?

See historical performance and comparison